Evidence map›Paper›PMID 37924378›Full record

ArticleDiabetologia2024

Apolipoprotein L genes are novel mediators of inflammation in beta cells.

Miriam Paz-Barba, Amadeo Muñoz Garcia, Twan J J de Winter, Natascha de Graaf, Maarten van Agen, Elisa van der Sar, Ferdy Lambregtse, Lizanne Daleman, Arno van der Slik, Arnaud Zaldumbide and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. HDL metabolism and function in diabetes mellitus.Nature reviews. Endocrinology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Proteomics data in vitiligo: a scoping review.Frontiers in immunology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Miriam Paz-BarbaDepartment of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Amadeo Muñoz GarciaDepartment of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Twan J J de WinterDepartment of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Natascha de GraafDepartment of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Maarten van AgenDepartment of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Elisa van der SarDepartment of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Ferdy LambregtseDepartment of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Lizanne DalemanDepartment of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Arno van der SlikDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
Arnaud ZaldumbideDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
Eelco J P de KoningDepartment of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Françoise CarlottiDepartment of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands. f.carlotti@lumc.nl.ORCID 0000-0001-7929-8468
Leiden University Medical Center · NL

Funding

Novo Nordisk Foundation Center for Stem Cell Medicine reNEW NNF21CC0073729
6 · The paper itself

Abstract

aims/hypothesisInflammation induces beta cell dysfunction and demise but underlying molecular mechanisms remain unclear. The apolipoprotein L (APOL) family of genes has been associated with innate immunity and apoptosis in non-pancreatic cell types, but also with metabolic syndrome and type 2 diabetes mellitus. Here, we hypothesised that APOL genes play a role in inflammation-induced beta cell damage.

methodsWe used single-cell transcriptomics datasets of primary human pancreatic islet cells to study the expression of APOL genes upon specific stress conditions. Validation of the findings was carried out in EndoC-βH1 cells and primary human islets. Finally, we performed loss- and gain-of-function experiments to investigate the role of APOL genes in beta cells.

resultsAPOL genes are expressed in primary human beta cells and APOL1, 2 and 6 are strongly upregulated upon inflammation via the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway. APOL1 overexpression increases endoplasmic reticulum stress while APOL1 knockdown prevents cytokine-induced beta cell death and interferon-associated response. Furthermore, we found that APOL genes are upregulated in beta cells from donors with type 2 diabetes compared with donors without diabetes mellitus. CONCLUSIONS/

interpretationAPOLs are novel regulators of islet inflammation and may contribute to beta cell damage during the development of diabetes. DATA AVAILABILITY: scRNAseq data generated by our laboratory and used in this study are available in the Gene Expression Omnibus (GEO; www.ncbi.nlm.nih.gov/geo/ ), accession number GSE218316.

Indexed as

Apolipoprotein L1InflammationInsulin-Secreting CellsDiabetes Mellitus, Type 2HumansInflammation MediatorsAPOL1 protein, humanApolipoprotein L1Inflammation MediatorsApolipoprotein LBeta cellsHuman isletsInflammation

Identifiers

PMID37924378
PMCPMC10709252
OpenAlexW4388344244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.